Aveo Pharmaceuticals, Inc.
AVEODelisted Jan 19, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001325879
Aveo Pharmaceuticals, Inc. was delisted on Jan 19, 2023; its insiders filed their last Form 4 on Jan 19, 2023; 110 institutions reported holding it in 13F filings for Q4 2022, worth $367.6M in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Aveo Pharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 74 | 62 | −12 |
| Shares | 13.9M | 14.3M | +428.5K (+3.1%) |
| Value | $101.4M | $94.2M | −$7.23M (−7.1%) |
New holders (15)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 1,821,176 | $12.0M | 0.76% |
| Ergoteles LLC | 97,800 | $645.0K | 0.01% |
| Pura Vida Investments, LLC | 97,547 | $643.0K | 0.05% |
| Susquehanna Fundamental Investments, LLC | 57,500 | $379.0K | 0.01% |
| Jump Financial, LLC | 50,900 | $336.0K | 0.03% |
| Tibra Equities Europe Ltd | 49,200 | $324.0K | 0.10% |
| Alps Advisors Inc | 45,254 | $298.0K | 0.00% |
| HRT Financial LP | 41,428 | $273.0K | 0.00% |
| Walleye Capital LLC | 21,813 | $144.0K | 0.01% |
| Qube Research & Technologies Ltd | 17,928 | $118.0K | 0.00% |
| Acadian Asset Management LLC | 14,289 | $94.0K | 0.00% |
| Blueshift Asset Management, LLC | 10,097 | $67.0K | 0.00% |
| Parallax Volatility Advisers, L.P. | 7,300 | $48.0K | 0.00% |
| TSFG, LLC | 292 | $2.00K | 0.00% |
| Ellevest, Inc. | 14 | $0 | 0.00% |
Sold out (27)
Institutions that held Aveo Pharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.